Passively inhaled tobacco smoke: a challenge to toxicology and preventive medicine
- PMID: 3326547
- DOI: 10.1007/BF00661366
Passively inhaled tobacco smoke: a challenge to toxicology and preventive medicine
Abstract
The difficulties in defining the exposure of a passive smoker might explain the controversial results regarding an association between passive smoking on one hand and lung cancer, tumors of all sites and ischemic heart diseases on the other. The plausibility of these epidemiological observations will be discussed in the light of analytical, toxicological, biochemical and oncological data. The minute amounts of nicotine and particulate matter, even the much higher concentrations of volatile substances, such as nitrosamines, NOx, acroleine and formaldehyde, present in diluted sidestream compared to mainstream smoke and breathed by involuntarily smoking people, cannot explain their relatively high cancer risk. It is plausible if one considers the high capacity of cigarette smoke to induce drug metabolizing enzymes. Diluted sidestream smoke, however, lacks compounds which induce several iso-enzymes of cyt. P-450 monooxygenase in the tissues. The best evidence is the up to 100-fold increase in placental enzymes if pregnant women smoke, whereas passively inhaled tobacco smoke is ineffective as inducer. The small amounts of paternal smoke inhaled by pregnant women, containing teratogenic and carcinogenic compounds, which are supposedly not detoxified in the placenta, seem to explain the higher risk for malformations of the fetus and the same or even increased risk for perinatal mortality, compared with the outcome of pregnancy if the mother smoked. The induction of placental enzymes very probably protects the fetus against the much higher amounts of toxic agents inhaled by the smoking mother. The increased activity of placental enzymes seems to be a model for the probably greater capacity of certain cyt. P-450 iso-enzymes in the lung and other tissues to convert carcinogens to inactive metabolites when the individual smokes actively. It is well known that concomitant administration of carcinogens with inducing agents inhibits tumor growth in animals because of a shift in the metabolism which favours the formation of ineffective substances. The negligible amounts of nicotine and CO in passively inhaled tobacco smoke cannot be responsible for the surprisingly high risk for ischemic heart diseases of passive smokers. A plausible explanation is offered by experiments with doves and chicken, which develop atherosclerotic lesions due to the action of carcinogens which are metabolized by certain inducible cyt. P-450 iso-enzymes in the aortic wall. Much circumstantial evidence will be presented, indicating that PAHs, contrary to the propagated opinion, play a minor role for the initiation of cancer in active smokers.(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
-
The changing cigarette, 1950-1995.J Toxicol Environ Health. 1997 Mar;50(4):307-64. doi: 10.1080/009841097160393. J Toxicol Environ Health. 1997. PMID: 9120872 Review.
-
Health hazards of passive smoking.Annu Rev Public Health. 1988;9:47-70. doi: 10.1146/annurev.pu.09.050188.000403. Annu Rev Public Health. 1988. PMID: 3288240 Review.
-
Lung cancer due to passive smoking--a review.Int Arch Occup Environ Health. 2001 May;74(4):231-41. doi: 10.1007/s004200000221. Int Arch Occup Environ Health. 2001. PMID: 11401014 Review.
-
Genotoxicity of environmental tobacco smoke: a review.Mutat Res. 2004 Nov;567(2-3):427-45. doi: 10.1016/j.mrrev.2004.06.004. Mutat Res. 2004. PMID: 15572289 Review.
-
[Environmental tobacco smoke--assessment of formaldehyde concentration in urine samples of exposed medicine students].Przegl Lek. 2015;72(3):140-3. Przegl Lek. 2015. PMID: 26731871 Polish.
Cited by
-
Elimination of cotinine from body fluids: disposition in smokers and nonsmokers.Am J Public Health. 1989 Aug;79(8):1046-8. doi: 10.2105/ajph.79.8.1046. Am J Public Health. 1989. PMID: 2751025 Free PMC article.
-
Hydroxyethylvaline adduct formation in haemoglobin as a biological monitor of cigarette smoke intake.Arch Toxicol. 1988;62(4):247-53. doi: 10.1007/BF00332482. Arch Toxicol. 1988. PMID: 3240090
-
Importance of exposure to gaseous and particulate phase components of tobacco smoke in active and passive smokers.Int Arch Occup Environ Health. 1990;62(6):459-66. doi: 10.1007/BF00379064. Int Arch Occup Environ Health. 1990. PMID: 2246065 Review.
-
Elevated blood levels of carcinogens in passive smokers.Am J Public Health. 1989 Oct;79(10):1381-4. doi: 10.2105/ajph.79.10.1381. Am J Public Health. 1989. PMID: 2782507 Free PMC article.
-
Lung cancer and passive smoking.Br J Cancer. 1991 Jan;63(1):161-3. doi: 10.1038/bjc.1991.37. Br J Cancer. 1991. PMID: 1989660 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical